Ex-Novartis Diagnostics President Assumes New Roles
This article was originally published in Scrip
Gene Walther, who was previously Novartis' diagnostics president, has been appointed head of NetScientific Plc.'s diagnostics franchise and will become the CEO of the company's portfolio company, Vortex BioSciences – effective Jan. 4, 2016. Walther replaces Vortex BioSciences' interim CEO, Michael Boyce-Jacino, who will leave the company and board of directors at the end of December 2015. Most recently Walther was consultant to the Paul G. Allen Family Foundation. Prior to this he was deputy director, diagnostics for the Bill & Melinda Gates Foundation and he also served as executive chair of GenturaDx's board. Walther spent over a decade at Novartis as president and global head of diagnostics.
Register for our free email digests: